$ Value
$0
Shares
11,430
Price
$0
Filed
Mar 26
Insider
Name
Balcom Alexandra
Title
Chief Financial Officer
CIK
0001862147
Roles
Transaction Details
Transaction Date
2026-03-24
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
150,226
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2025. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.34 to $95.33, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) of this Form 4. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.35 to $96.34, inclusive. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.35 to $96.72, inclusive. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.00 to $100.61, inclusive. | The shares underlying this option are fully vested.
Filing Info
Balcom Alexandra's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | NUVL | M | $12K |
| 2026-04-01 | NUVL | ▼ | $370K |
| 2026-04-01 | NUVL | ▼ | $570K |
| 2026-04-01 | NUVL | ▼ | $262K |
| 2026-04-01 | NUVL | M | $0 |
| 2026-03-25 | NUVL | ▼ | $1.4M |
| 2026-03-24 | NUVL | M | $12K |
| 2026-03-24 | NUVL | ▼ | $247K |
| 2026-03-24 | NUVL | ▼ | $735K |
| 2026-03-24 | NUVL | ▼ | $112K |
Other Insiders at NUVL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Balcom Alexandra
Chief Financial Officer
|
— | $3.7M | 2026-04-01 |
|
Noci Darlene
Chief Development Officer
|
— | $538K | 2026-03-30 |
|
Porter James Richard
President and CEO
|
— | $3.1M | 2026-04-06 |
|
Miller Deborah Ann
Chief Legal Officer
|
— | $543K | 2026-03-26 |
|
Pelish Henry E.
Chief Scientific Officer
|
— | $323K | 2026-04-09 |
|
Lane Benjamin
See Remarks
|
— | — | 2026-04-01 |